Capricor Therapeutics, Inc. (CAPR)
NASDAQ·Healthcare·Biotechnology
$4.22
+0.36%
Mkt Cap $242.65M
Analyst Ratings
Buy
5
Hold
4
Sell
0
Price Target (20 analysts)
$5.83
Range $3.50 – $7.00
Implied Upside
+38.3%
Consensus $5.83 vs current $4.22
NASDAQ·Healthcare·Biotechnology
$4.22
+0.36%
Mkt Cap $242.65M
Buy
5
Hold
4
Sell
0
Price Target (20 analysts)
$5.83
Range $3.50 – $7.00
+38.3%
Consensus $5.83 vs current $4.22